Long-Term Risk for MACE Increased for Children With Hypertension
By Elana Gotkine HealthDay Reporter
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May 6 in JAMA Pediatrics to coincide with the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.
Cal H. Robinson, M.D., from The Hospital for Sick Children in Toronto, and colleagues examined the long-term associated risk for MACE among children with hypertension in a population-based, retrospective cohort study conducted from 1996 to 2022. Data were included for 25,605 children with hypertension compared with 128,025 controls without hypertension matched by age, sex, birth weight, maternal gestational hypertension, prior comorbidities, and a propensity score for hypertension.
The researchers found that the incidence of MACE was 4.6 and 2.2 per 1,000 person-years in children with hypertension and controls, respectively (hazard ratio, 2.1), during a median follow-up of 13.6 years. Higher associated risks for stroke, hospitalization for myocardial infarction or unstable angina, coronary intervention, and congestive heart failure were seen for children with hypertension, but there was no increase in risk seen for cardiovascular death.
"Optimizing the care provided to youth with hypertension may help prevent long-term adult cardiovascular disease, with substantial health and cost-saving benefits," the authors write.
Two authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors
THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.